Changes in body water compartments with diuretic therapy in infants with chronic lung disease

J L Segar1, S Chemtob, E F Bell

  • 1Department of Pediatrics, University of Iowa, Iowa City 52242, USA.

Insights

Diuretic therapy in preterm infants with chronic lung disease reduced extracellular water. Combination therapy with furosemide and metolazone increased urine output more effectively.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nephrology
  • Respiratory Medicine

Background:

  • Chronic lung disease is common in preterm infants.
  • Fluid management is critical in these vulnerable infants.
  • Diuretics are often used to manage fluid overload.

Purpose of the Study:

  • To investigate the effects of diuretic therapy on body water compartments in preterm infants with chronic lung disease.
  • To compare the efficacy of furosemide alone versus furosemide plus metolazone.

Main Methods:

  • Randomized study of preterm infants (24-28 weeks gestational age) with chronic lung disease.
  • Infants received either furosemide alone or furosemide plus metolazone for 4 days.
  • Body water compartments, including extracellular water (ECW) and plasma volume (PV), were assessed.

Main Results:

  • Both treatment groups showed a significant decrease in ECW (P < 0.05) without changes in PV, total body water, or body weight.
  • The reduction in ECW was similar between the furosemide-only and combination therapy groups.
  • Combination therapy with furosemide and metolazone significantly increased urine output compared to furosemide alone.

Conclusions:

  • Diuretic therapy in preterm infants with chronic lung disease causes intercompartmental shifts in body water, reducing interstitial water while preserving plasma volume.
  • Combination therapy with furosemide and metolazone is more effective in inducing diuresis than furosemide alone.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Formation of Dilute Urine01:20

Formation of Dilute Urine

The formation of dilute urine is a critical renal adaptation that maintains fluid balance, particularly during periods of high fluid intake. This process primarily involves the juxtamedullary nephrons. By adjusting the permeability of water and ions in response to physiological conditions, the kidneys can either conserve or excrete water, resulting in concentrated or dilute urine.
Filtrate Osmolarity in the PCT
Initially, as the filtrate passes through the proximal convoluted tubule (PCT), its...
Disorder of Water Balance01:29

Disorder of Water Balance

Water balance disorders are medical conditions that occur when there is a deviation from the body's water volume or osmolarity, disrupting normal homeostasis and leading todehydration, hypotonic hydration, hyperhydration, edema, or water intoxication.
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...